USA · PI Dr. Novak · activated
Patients
23
Active
0
Serious AEs
1
Open QA
0
Aged queries
0
Luna users
0
Studies & contracts
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II · study completed · contract executed · 263500 USD
Patients (23)
709-1001 ›
completed
709-1007 ›
completed
709-1020 ›
completed
709-1029 ›
completed
709-1081 ›
completed
709-1088 ›
completed
709-1099 ›
completed
709-1102 ›
completed
709-1168 ›
completed
709-1217 ›
completed
709-1224 ›
screened
709-1237 ›
screened
709-1238 ›
completed
709-1259 ›
completed
709-1285 ›
completed
709-1301 ›
completed
709-1306 ›
completed
709-1309 ›
completed
709-1312 ›
completed
709-1326 ›
completed
709-1329 ›
withdrawn
709-1339 ›
completed
709-1424 ›
completed
Safety — 122 AEs, 1 serious
serious
709-1424
Moderate SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-03-07 (study day 5.0); relationship: POSSIBLE; serious criteria: life-threatening
QA findings (0 open)
No findings recorded.
Visits & payments
Nothing scheduled.
☾ Luna participants
No Luna participants here yet.